LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.21
+0.03 (0.42%)
At close: Jan 21, 2026, 4:00 PM EST
7.19
-0.02 (-0.28%)
After-hours: Jan 21, 2026, 7:31 PM EST
LifeStance Health Group Market Cap
LifeStance Health Group has a market cap or net worth of $2.8 billion as of January 21, 2026. Its market cap has decreased by -2.92% in one year.
Market Cap
2.80B
Enterprise Value
3.08B
1-Year Change
-2.92%
Ranking
Category
Stock Price
$7.21
Market Cap Chart
Since the IPO on June 10, 2021, LifeStance Health Group's market cap has decreased from $6.73B to $2.80B, a decrease of -58.30%. That is a compound annual growth rate of -17.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 2.79B | 1.99% |
| Dec 31, 2025 | 2.74B | -2.89% |
| Dec 31, 2024 | 2.82B | -4.87% |
| Dec 29, 2023 | 2.96B | 59.61% |
| Dec 30, 2022 | 1.86B | -47.85% |
| Dec 31, 2021 | 3.56B | -47.04% |
| Jun 10, 2021 | 6.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |